Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Total Assignments:
4
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17123777
|
Filing Dt:
|
12/16/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/17/2021
| | | | |
|
Inventors:
|
Darren Anthony Edward Cross, Catherine Anne Eberlein
|
|
Title:
|
Combination of EGFR Inhibitor and MEK Inhibitor for use in the treatment of NRAS mutated cancer
|
|
|
Assignment:
1
|
|
|
|
|
|
|
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ERRONEOUS FILING DATE OF ASSIGNMENT IN THE WRONG APPLICAITON AND REMOVE ASSIGNMENT FOR THE OTHER PARTIES APPLICATIONS PREVIOUSLY RECORDED AT REEL: 055549 FRAME: 0451. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
|
|
|
|
|
|
|
|
|
| 1 FRANCIS CRICK AVENUE |
| CAMBRIDGE BIOMEDICAL CAMPUS |
| CAMBRIDGE, UNITED KINGDOM CB2 0AA |
|
|
|
|
| ASTRAZENECA |
| ONE MEDIMMUNE WAY |
| GAITHERSBURG, MD 20878 |
|
|
|
Assignment:
2
|
|
|
|
|
|
|
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ERRONEOUS FILING OF ASSSIGNMENT IN THE WRONG APPLICATION PREVIOUSLY RECORDED AT REEL: 055548 FRAME: 0378. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
|
|
|
|
|
|
|
|
|
| 1 FRANCIS CRICK AVENUE |
| CAMBRIDGE BIOMEDICAL CAMPUS |
| CAMBRIDGE, UNITED KINGDOM CB2 0AA |
|
|
|
|
| ASTRAZENECA |
| ONE MEDIMMUNE WAY |
| GAITHERSBURG, MD 20878 |
|
|
|
Assignment:
3
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| SE-151 85 |
| SÖDERTÄLJE, SWEDEN |
|
|
|
|
| ASTRAZENECA |
| ONE MEDIMMUNE WAY |
| GAITHERSBURG, MD 20878 |
|
|
|
Assignment:
4
|
|
|
|
|
|
|
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 17123177 PREVIOUSLY RECORDED AT REEL: 055548 FRAME: 0389. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT .
|
|
|
|
|
|
|
|
|
| SE-151 85 |
| SODERTALJE, SWEDEN |
|
|
|
|
| ASTRAZENECA |
| ONE MEDIMMUNE WAY |
| GAITHERSBURG, MD 20878 |
|
|
Search Results as of:
06/26/2024 02:20 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
